April 29, 2024
Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma.
Breakthrough: Genetically Engineering Treatment For Incurable Brain Tumors
April 29, 2024
A team of four Purdue researchers—three from Polytechnic departments, one of whom is also an undergraduate—have just unveiled new research on stress and fatigue among college students.
Polytechnic-led research project investigates stress symptoms, compares pilots vs. other college students
April 26, 2024
Alzheimer’s disease is one of the top ten leading causes of death in the United States, according to the Alzheimer’s Association, and the number of millions of people affected by it each year continues to rise. The prevalence of the disease, the lack of treatments and knowledge gap, and an interest in how the brain functions led Priyanka Baloni, assistant professor in the Purdue University School of Health Sciences, on a quest to understand possible treatments for the condition.
PURDUE HEALTH SCIENCES RESEARCHER’S INNOVATIVE METABOLIC NETWORK MAKES ADVANCES TOWARD ALZHEIMER’S DISEASE TREATMENTS
April 24, 2024
A concrete strength sensing system invention from Purdue University could reduce cost and time spent on concrete construction.
Invention from Purdue University could drastically improve concrete construction
April 24, 2024
A Purdue University professor’s invention that measures concrete strength for highway traffic won gold at the Edison Awards in its Best New Products competition on April 18 in the Critical Human Infrastructure category, according to the award’s website.
April 23, 2024
Researchers at Purdue University have made groundbreaking strides in developing a novel treatment for glioblastoma brain tumors, a condition deemed incurable with conventional therapies.
April 23, 2024
A new type of immunotherapy drug appears to be more effective than other approaches at stimulating the immune response, the results of a study published April 19 in Nature Biomedical Engineering show.
Combining the 'best of two worlds' to boost immunotherapy response in mice with breast cancer
April 23, 2024
Hot flashes are one of the most commonly discussed side effects of menopause, but the decline of ovarian hormones and its effect on the gut microbiome can also increase the risk of a variety of metabolic diseases, including obesity and cardiometabolic syndrome, according to a recent publication by Tzu-Wen Cross, assistant professor in Purdue University’s Department Nutrition Science.
PURDUE NUTRITION SCIENCE RESEARCHER UNCOVERS CONNECTION BETWEEN HORMONES, GUT MICROBIOME AND METABOLIC DYSFUNCTION COMMONLY SEEN IN POSTMENOPAUSAL WOMEN
April 23, 2024
As the world emerges from the COVID-19 pandemic, there is an urgent need to understand patient factors that may be used to predict the occurrence of severe cases and patient mortality.
Identification of predictive patient characteristics for assessing the probability of COVID-19 in-hospital mortality
April 22, 2024
Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma.
Genetically engineering a treatment for incurable brain tumors
